Viral populations are complex, dynamic, and fast evolving. The evolution of groups of closely related viruses in a competitive environment is termed quasispecies. To fully understand the role that quasispecies play in viral evolution, characterizing the trajectories of viral genotypes in an evolving population is the key. In particular, longrange haplotype information for thousands of individual viruses is critical; yet generating this information is non-trivial. Popular deep sequencing methods generate relatively short reads that do not preserve linkage information, while third generation sequencing methods have higher error rates that make detection of low frequency mutations a bioinformatics challenge. Here we applied BAsE-Seq, an Illumina-based single-virion sequencing technology, to eight samples from four chronic hepatitis B (CHB) patientsonce before antiviral treatment and once after viral rebound due to resistance. We obtained 248-8,796 single-virion sequences per sample, which allowed us to find evidence for both hard and soft selective sweeps. We were also able to reconstruct population demographic history that was independently verified by clinically collected data. We further verified four of the samples independently on PacBio and Illumina sequencers. Overall, we showed that single-virion sequencing yields insight into viral evolution and population dynamics in an efficient and high throughput manner. We believe that single-virion sequencing is widely applicable to the study of viral evolution in the context of drug resistance, differentiating between soft or hard selective sweeps, and the reconstruction of intra-host viral population demographic history.
Introduction
Viral intra-host evolution is a critical obstacle in the treatment of infectious diseases. It is the root cause of viral host immune escape and drug resistance, and consequently a major impediment in disease cure and eradication [Hughes and Andersson 2015, Presloid and Novella 2015] . The hepatitis B virus (HBV) is a prime example. HBV is a small, circular DNA virus with a high mutation rate (µ = 10 -5 to 10 -7 ) [Caligiuri et al., 2016] . When coupled with a large viral load (often between ~10 3 copies/ml to 10 7 copies/ml of serum), this can give substantial viral diversity in active infections [Osiowy et al., 2006 ]. In other words, a sufficiently large viral population can potentially carry, or produce within a short period of time, all possible mutations, thus providing a genetic reservoir for rapid viral response and adaptation [Yim et al., 2006 [Sterneck et al., 1997 , Gunther et al., 1999 , Hannoun et al., 2000 . Mutations that quickly become predominant in the population are also indicators for how the viruses might be circumventing host response and treatment that enable fresh approaches for drug development research [Chisari and Ferrari 1995] .
Mutations play a vital role in evolution, but the concept of quasispecies is also an important model in viral evolutionary genetics [Eigen 1971 , Eigen 1996 The term quasispecies initially stemmed from the notion that an evolving population of macromolecules is heterogeneous. Mutation-selection balance in a highly mutable viral population results in populations made up of many similar but non-identical viral sequences, also called mutant clouds. Although the precise definition and exact scope of quasispecies have been debated Moya 2002, Lauring et al., 2013] , there is substantial support that some form of quasispecies exists in HBV [Simmonds and Midgley 2002 , Osiowy et al., 2006 , Domingo et al., 2012 . Having a genetic repository in the form of stable covalently closed circular DNA (cccDNA) in infected hepatocytes ensures the constant presence of ancestral sequence(s), while rapid replication with a high error rate provides the necessary genetic heterogeneity to sustain mutant clouds.
The implications for studying HBV viral evolution are as follows. First, consensus sequence changes occur relatively slowly. For HBV, the mean number of nucleotide substitutions is only estimated at between 1.5 × 10 −5 to 7.9 × 10 −5 nucleotide substitutions per site per year [Osiowy et al., 2006 ]. The study of consensus sequences alone may not reveal underlying quasispecies dynamics, which may be much more rapid as the population constantly explores possible genotypes [Domingo et al., 2012] . Second, these hidden quasispecies dynamics may be important in understanding the key indicators of viral fitness. Human host immune response, host genetics, treatment regimes, and finally the viral genotype itself likely interact in a complex fashion that exerts multiple, possibly contradictory selective forces on the virus that ultimately culminates in clinical outcome. Identifying the relevant subpopulation of viruses that are reacting to selective pressures of interest, whether it is nucleoside analogues, interferon treatments, or a change in host immune response can reveal important viral indicators for disease progression.
In order to leverage the recent advancements in next generation sequencing (NGS) technology, we explored single-virion sequencing as an option for characterizing quasispecies diversity in active infections. Deep population sequencing is routinely used to identify polymorphisms, including extremely rare alleles [Widasari et al., 2014 , Yamani et al., 2015 , Yan et al., 2015 , Li et al., 2015 , Ode et al., 2015 , Chen et al., 2016 .
However, without linkage information, it remains difficult to describe quasispecies based on allele frequencies alone. A large number of complete genomes from a single viral population must be sequenced to be confident of full quasispecies diversity.
Traditionally, such studies require viruses to be individually cloned and sequenced -a tedious, non-scalable process requiring a large amount of work and precious source material [Osiowy et al., 2006 , Lim et al., 2007 . Quite often, quasispecies are simply left out in the study of viral evolution. However, the complexity and importance of quasispecies has never been clearer [Andino and Domingo 2015] , and there are two recent next NGS technologies that can be applied to single-virion sequencing in a highthroughput manner, promising up to thousands of viral sequences from every chronic hepatitis B (CHB) patient sample. BAsE-Seq is an Illumina-based method that makes use of random 20mer barcodes to tag every single viral genome with a unique sequence. The barcoded genomes are then amplified as a single amplicon for library construction [Hong et al., 2014] . Reads from BAsE-Seq libraries can be reassembled into individual viral genomes in silico post sequencing, effectively constructing thousands of viral genomes with full haplotype information. An alternative approach uses single molecule real time sequencing technology (SMRT) on the Pacific Biosciences platform (PacBio) to produce long reads for individual molecules (up to 60kb). While single pass sequencing error rates are high, the relatively small 3kb HBV genomes can be read multiple times by the same polymerase, sharply lowering error rates and yielding highly accurate genome sequences, with the additional benefit of not requiring a reference genome [Dilernia et al., 2015] .
We aimed to apply these single-virion sequencing methods in a manner tailored to characterizing viral population diversity, quasispecies structure, and population evolution. More specifically, we aimed to discover additional information on viral evolutionary dynamics not visible to regular deep sequencing that is now detectable with single-virion sequencing. We picked a relatively well-understood model -that of HBV resistance to the antiviral drug Lamivudine, where the most common resistance alleles are well characterized [Pallier et al., 2006] , and obtained two serum samples from each of four CHB patients who were treated with and subsequently developed resistance to Lamivudine. We searched for resistance mutations in each of the patients and tried to reveal additional quasispecies dynamics using single-virion sequencing. We found that single-virion sequencing reveals vital information about viral population heterogeneity and fluctuations in population composition during viral evolution. Table 1 ). Plasmids with clones HBV sequences (referred to as Clone-1 and Clone-2 in the text) were constructed and processed as previously detailed in [Hong et al., 2014] .
Material and methods

Sample Identification and Collection in the Clinic
Illumina Library Construction and Sequencing
For a detailed protocol for sample library preparation, refer to [Aw et al., 2014] . Briefly, 10 6 HBV viral genomes were PCR amplified using custom primers that cover all but the first 40bp. 2-3 µg of PCR product for each viral DNA sample was sheared to achieve a peak size range of 100-300 bp. Library preparation was performed using the Qiagen 
Barcode-directed Assembly for Extra-long Sequences (BAsE-Seq)
Library preparation was carried out according to the protocol as described in [Hong et al., 2014] . Briefly, a total of 10 6 HBV genomes were subjected to a 2-cycle PCR that assigned unique barcodes to each strand of the HBV genome. Two rounds of PCR were carried out to amplify the product, using HBV specific primers (5′-GCTCTTCTTTTTCACCTCTGCCTAATCA-3′ and 5′-GCTCTTCAAAAAGTTGCATGGTGCTGG-3′), taking care to stay within the exponential amplification regime during each round of PCR to minimize the generation of chimeric PCR products. Samples were exonuclease-digested to generate a pool of nested deletions, end-repaired, and circularized. Circular products were fragmented and tagged with the Illumina adaptors followed by 14 cycles of PCR to incorporate primers for sequencing. The resulting 2×101bp reads were processed with a custom pipeline. In the pipeline, FastQ reads were first trimmed for adaptor sequences and base quality. 
Reconstruction of Demographic History by BEAST
Results and Discussion
Deciding On An Appropriate Platform
The three platforms -Illumina (pooled deep sequencing), BAsE-Seq, and PacBio SI Fig 3] . We bypassed this issue by making use of the available reference sequences to map PacBio reads, with the additional bonus of ease of comparison across platforms due to similar analysis pipelines (SI 6-7, [9] [10] [11] [12] [13] [14] [15] . However, this also resulted in a protocol that neither required nor fully utilized the advantages of a reference independent sequencing technology. As such, BAsE-Seq with its lower error rates overall became the appropriate choice. A more detailed explanation of all work conducted in this comparison exercise is available in Supplementary Materials.
Classic Resistance Mutations Observed
Serum samples were taken from each patient twice for viral DNA library construction -once before they were treated with Lamivudine (labeled as P1.1, P2.1, P7.1, P11.1) and once after viral loads rebounded to detectable levels (labeled as P1.2, P2.2, P7.2, P11.2) ( Table 1) . They confer similarly high resistance and only require one to two nucleotide changes.
Both of these resistant genotypes were found, and together explained resistance in all four patients ( Table 2 . The frequencies of detected resistance alleles in each of the 4 patients after drug resistance. None of these mutations were observed (below detection limit) in the populations prior to development of resistance.
While P2 (M204I) and P7 (M204V+ L180M) carried single resistance phenotypes, P1
carried both M204I and M204V+ L180M. The genotypes are not mutually exclusive and all three of the point mutations were found in the same patient at significant frequencies (Figure 3,4) . P11 was nearly fixed for M204I, but also carried L180M at a high frequency. infection seeded by very few drug-naïve virions is less likely to carry pre-existing resistance alleles as compared to a mixed infection or a long-term infection that has had time to diversify within the patient. There is also the possibility that a large, highly mutable viral population could theoretically carry all possible mutations in its quasispecies mutant pool at any point in time. Determining the correct model for HBV population evolution will be important for describing and modeling adaptation.
Viral Quasispecies Reveal Both Hard and Soft Selective Sweeps
We made use of nearly full genome haplotype information from BAsE-Seq to characterize viral population quasi-species composition before and after drug treatment.
Phylogenetic trees built from viral haplotypes revealed three different patterns in how these patients gained viral resistance.
Two patients, P2 and P7, had trees that showed clear mono-clonal gains of resistance, suggestive of hard sweeps (Figure 5,6 ). Allele frequency changes showed clusters of SNVs that increased in allele frequency together (11 SNVs in P2 spanning the entire 3.2kb sequenced region [ Figure 3 ] and 6 SNVs in P7 spanning 2kb-2.8kb [ Figure   4 ]). Haplotype information confirmed that these were linked SNVs on the same haplotype. 9/11 SNVs in the P2 cluster were within the RT domain of the polymerase gene, and 7/11 SNVs were non-synonymous mutations within a 750bp window. All six SNVs in the P7 cluster were within the RT domain of the polymerase gene, and three were non-synonymous mutations within a 150bp window. These two sweeps with numerous SNVs linked to the resistance allele would support a model of evolution from standing variation. However, these exact combinations of SNVs were not found in the treatment naïve timepoints for either patient. The closest haplotypes found pre-treatment shared just 6/11 SNVs for P2 and 2/6 SNVs for P7. We suggest three possible explanations. First, there could be a detection limit for extremely rare haplotypes in the pre-treatment timepoints. We may simply have failed to sequence them. Second, because our samples came from patient blood samples, latent viral reservoirs outside of the blood stream could be contributing to the viral population. Again, they would be missed by serum samples. Finally, the resistance mutation could have occurred later during the treatment regime by chance, and happened to rise on the background of a viral sequence that already accumulated multiple nucleotide differences from the population consensus.
There was in fact a two to three fold difference in nucleotide diversity across the eight patient samples (Table 1 ), suggesting a range of quasispecies complexity across patients, which may affect observed evolutionary dynamics.
The two remaining patients, P1 and P11, had trees showing at least two independent instances of gain of resistance, in other words soft sweeps (Figure 7,8 ). P1
was highly clonal with just 6 sites shifting in frequency over time (Figure 3) , and independently gained M204I and L180M+M204V on two haplotypes. P11 carried the most diverse population out of all four patients, starting as a mixed population of 26% Genotype B and 74% Genotype C ( Figure 2 ). The same resistance allele M204I evolved twice on Genotype C sequences but none on Genotype B sequences, resulting in a resistant viral population that was 100% Genotype C. One lineage further gained the L180M mutation, although it is unclear whether that conferred additional resistance on a M204I background.
Reconstructing Demographic History
The BEAST analysis for P11 showed effective samples sizes (ESS) of >500, indicating convergence. Sequences came from day 1233 (sample before Lamivudine treatment) and day 0 (sample taken after viral resistance and consequently viral load rebound).
Reconstructed demographic history showed an initial exponential growth phase post infection, followed by a plateau. A sharp dip in effective viral population size (N e ) then occurred sometime between 750-1350 days prior to day 0. From actual patient viral load information, the population crash post drug treatment occurred sometime around day 1250. There was also a sharp increase in median N e about 150 days prior to day 0 in the skyline plot, which matched actual clinical data almost perfectly (Figure 9 ). Although the two major changes in population size were well identified, a smaller increase in the viral population size around day 700 was not, possibly indicating some limitations when reconstructing smaller scale changes in population demography, or that these viruses did not contribute to the effective population size. Due to the smaller nucleotide diversity present in the other patient samples (Table 1) , runs for P1, P2 and P7 did not coalesce at 1E9 replications (SI Figures 20-22 ).
Conclusions
Haplotype information is vital for revealing hidden population dynamics invisible in standard deep sequencing data. While single-virion sequencing remains technically challenging, we employed two complementary single-virion sequencing platforms to reveal -and cross-validate -such information. We can tell, from nucleotide diversity calculations, the heterogeneity of a population. We can estimate, using hundreds to thousands of single-virion haplotypes, the relative proportions of genotypes and quasispecies present in an infection. We can determine if resistance evolved from a single source, or multiple times independently. Using samples taken at different timepoints, we can begin to explore whether evolution occurs from standing variation or de novo mutations, and how that is linked to quasispecies complexity. While lamivudine resistance is a relatively simple adaptive process with very specific alleles conferring fitness gains, this work shows the potential of applying single-virion sequencing to complex events such as viral response to immune enhancement or viral dynamics during an active HBV flare. It may also be valuable in the study of difficult topics such as cccDNA stability, viral recombination, and viral reservoirs. Single-virion sequencing is therefore a powerful tool for understanding the role of viruses across disease stages of clinical importance.
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